Literature DB >> 20367477

Neutralizing antibodies to the hookworm hemoglobinase Na-APR-1: implications for a multivalent vaccine against hookworm infection and schistosomiasis.

Mark S Pearson1, Darren A Pickering, Leon Tribolet, Leanne Cooper, Jason Mulvenna, Luciana M Oliveira, Jeffrey M Bethony, Peter J Hotez, Alex Loukas.   

Abstract

The aspartic protease of Necator americanus, Na-APR-1, is a vaccine antigen that induces antibodies that neutralize hemoglobin proteolysis in the gut of the worm. To define the epitopes recognized by these antibodies, monoclonal antibodies (mAbs) were raised and assessed for neutralizing activity. Three immunoglobulin (Ig) G1 mAbs bound to the intestine of N. americanus and inhibited Na-APR-1 enzymatic activity. Overlapping fragments of Na-APR-1 were expressed, and one (APR-1/5B) was recognized by all 3 mAbs; the epitope was further characterized as AGPKAQVEAIQKY (A(291)Y). This same peptide with a Phe/Tyr(303) substitution was recognized by mAbs in APR-1 orthologues from Ancylostoma species hookworms. IgG from humans infected with hookworms did not recognize A(291)Y but, rather, recognized the S(107)L epitope. APR-1/5B was fused to other helminth vaccine antigens, including Schistosoma mansoni Sm-TSP-2 and N. americanus Na-GST-1; antibodies against both chimeras neutralized the enzymatic activity of Na-APR-1. These findings support the incorporation of Na-APR-1 into a multivalent vaccine against hookworm and/or schistosomiasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20367477     DOI: 10.1086/651953

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  23 in total

Review 1.  Developing vaccines to combat hookworm infection and intestinal schistosomiasis.

Authors:  Peter J Hotez; Jeffrey M Bethony; David J Diemert; Mark Pearson; Alex Loukas
Journal:  Nat Rev Microbiol       Date:  2010-11       Impact factor: 60.633

Review 2.  A history of hookworm vaccine development.

Authors:  Brent Schneider; Amar R Jariwala; Maria Victoria Periago; Maria Flávia Gazzinelli; Swaroop N Bose; Peter J Hotez; David J Diemert; Jeffrey M Bethony
Journal:  Hum Vaccin       Date:  2011-11-01

3.  Prevalence of hookworm infection: a retrospective study in Kumasi.

Authors:  Williams Walana; Eric Nana Kofi Aidoo; Samuel Crowther Kofi Tay
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

Review 4.  Vaccines to combat the neglected tropical diseases.

Authors:  Jeffrey M Bethony; Rhea N Cole; Xiaoti Guo; Shaden Kamhawi; Marshall W Lightowlers; Alex Loukas; William Petri; Steven Reed; Jesus G Valenzuela; Peter J Hotez
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

5.  The potential economic value of a hookworm vaccine.

Authors:  Bruce Y Lee; Kristina M Bacon; Rachel Bailey; Ann E Wiringa; Kenneth J Smith
Journal:  Vaccine       Date:  2010-12-16       Impact factor: 3.641

6.  Antibody-mediated trapping of helminth larvae requires CD11b and Fcγ receptor I.

Authors:  Julia Esser-von Bieren; Beatrice Volpe; Manuel Kulagin; Duncan B Sutherland; Romain Guiet; Arne Seitz; Benjamin J Marsland; J Sjef Verbeek; Nicola L Harris
Journal:  J Immunol       Date:  2014-12-29       Impact factor: 5.422

7.  New tools for NTD vaccines: A case study of quality control assays for product development of the human hookworm vaccine Na-APR-1M74.

Authors:  Mark S Pearson; Amar R Jariwala; Giovanni Abbenante; Jordan Plieskatt; David Wilson; Maria Elena Bottazzi; Peter J Hotez; Brian Keegan; Jeffrey M Bethony; Alex Loukas
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

8.  Haematophagic Caenorhabditis elegans.

Authors:  Veeren M Chauhan; David I Pritchard
Journal:  Parasitology       Date:  2018-10-25       Impact factor: 3.234

9.  Lipid core peptide targeting the cathepsin D hemoglobinase of Schistosoma mansoni as a component of a schistosomiasis vaccine.

Authors:  Annette M Dougall; Mariusz Skwarczynski; Makan Khoshnejad; Saranya Chandrudu; Norelle L Daly; Istvan Toth; Alex Loukas
Journal:  Hum Vaccin Immunother       Date:  2013-11-14       Impact factor: 3.452

10.  Peptide-based subunit vaccine against hookworm infection.

Authors:  Mariusz Skwarczynski; Annette M Dougall; Makan Khoshnejad; Saranya Chandrudu; Mark S Pearson; Alex Loukas; Istvan Toth
Journal:  PLoS One       Date:  2012-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.